Business
At Teradata, we are taking a different approach: we start with real-world uses and build platforms that help our customers deliver business outcomes, at scale.
TERADATA CORP /DE/: Revenue declined 5% to $1.663B from $1.75B. Net income grew 14% to $130M from $114M. Free cash flow grew 2.5% to $286M from $279M. Operating margin expanded 39 bps to 12.33%. TERADATA CORP /DE/'s annual comparison also shows the balance-sheet screen falls in the distress range and requires business-model context.
The read at a glance✓ Audited against SEC data
- Growth — Revenue declined 5% to $1.663B from $1.75BWatch
- Profitability — Net income grew 14% to $130M from $114MOK
- Cash flow — Free cash flow grew 2.5% to $286M from $279MOK
- Margins — Operating margin expanded 39 bps to 12.33%OK
- Accounting — Distress-range screen needs contextWatch
- Insiders — 0 purchases and 10 salesWatch
Where the revenue comes from
Fiscal 2025, as TERADATA CORP /DE/ reports it. History and quarterly detail are in the app.
- Product Sales$1.5B
- Consulting Services$201.0M
Leadership changes
From TERADATA CORP /DE/'s own filings, the day they're filed.
- Richard Petley · Chief Revenue Officer · appointmenteff. 2024-04-05
- Fishback's Retirement · director · departure
Latest filings
- 8-K · Company announcement2026-08-17
- 10-Q · Quarterly report2026-08-05
- 8-K · Company announcement2026-08-04
- 8-K · Company announcement2026-08-03
- 8-K · Company announcement2026-06-24
In the full recordFree for 14 days
- What changed🔒
- Insider signal🔒
- Growth quality🔒
- Margins & accounting🔒
- Capital allocation🔒
- Real risks🔒
- The long arc🔒
- Company history🔒
- The filings, readable — with what changed vs the prior year highlighted🔒
- Full financial statements, industry-aware, sources cited throughout🔒
- Forensic score history & components — the trend, not one year🔒
- Ownership: insider buys/sells, clusters, activist stakes🔒
- Ana — ask about TERADATA CORP /DE/, every answer cited to the official filings🔒
Every figure comes from the company's filings, and analysis whose figures don't match SEC data is rejected before publication.
14-day free trial, no credit card. For research purposes only; not investment advice.